Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy

Brian C. Baumann, Dennis E. Hallahan, Jeff M. Michalski, Carlos A. Perez, James M. Metz

Research output: Contribution to journalComment/debate

Abstract

Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of controversy and data are relatively limited. We comment on recently published studies and discuss future directions for proton therapy.

Original languageEnglish
Pages (from-to)869-870
Number of pages2
JournalBritish Journal of Cancer
Volume123
Issue number6
DOIs
StatePublished - Sep 15 2020

Fingerprint Dive into the research topics of 'Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy'. Together they form a unique fingerprint.

Cite this